DRG Instruments GmbH
Booth number: H1.G50
www.drg-diagnostics.de
About us
DRG – More than 50 Years of Innovative Diagnostics
DRG Instruments GmbH – A BioCheck Company – strives to become your one-stop-shop for daily clinical and research workflow. Our company offers CLIA & ELISA automated instruments in both low and medium throughput options with support for over 100 different assays. We also offer wide ranges of antibodies and manual ELISAs that meet all levels of the diagnostic world. Our products are manufactured at our high quality GMP facility in Marburg, Germany, and are rigorously tested and inspected prior to distribution.
The company's global distribution network covers all 6 inhabited continents (North America, South America, Africa, Asia, Europe, and Australia).
This year we are excited to introduce to the market with our latest CLIA innovation for detecting Traumatic Brain Injury. Visit us at booth H1.G50 to learn more about our new brain disorder innovation and find out how DRG Instruments GmbH can be your clinical and research partner!
Address
Frauenbergstr. 18
35039 Marburg
Germany
E-mail: info@drg-diagnostics.de
Phone: +49 6421 17000
Internet: www.drg-diagnostics.de
Products & Services
DRG is specialized in the development and production of innovative immunoassays, for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function, iron metabolism, saliva diagnostics, infectious diseases and many more.
DRG is also the manufacturer of the DRG:HYBRiD-XL, a fully automated analyzer for immunoassays and clinical chemistry. The assay menu includes routine as well as niche parameters. Recently DRG has launched a new product group for the fully automatic determination of antibiotic TDMs for DRG:HYBRiD-XL.
Furthermore, DRG & BioCheck are excited to add to the automation portfolio with CLIA devices DxDATA & DxDATA Nano and its associated menu of reagent assays, and ELISA devices, DYNEX DSX and DS2 instruments, with an addition of automation technical service to better customer’s with the ELISA automation experience.
DRG:HYBRiD•XL® Fully Automated Random-Access Analyzer For Immunoassays and Clinical Chemistry
The DRG:HYBRiD•XL® analyzer is designed to simultaneously perform reliable immunoassays and clinical chemistry testing, including turbidimetric tests from one patient sample, delivering a very flexible and easy method to meet the demands of the laboratory.
The DRG:HYBRiD-XL® assays are available for added convenience and efficiency.
Calprotectin on DRG:HYBRiD-XL
Fully automated immunoassay for the quantitative determination of Calprotectin in stool
DRG Infectious Diseases ELISAs
DRG Instruments GmbH A BioCheck Company offeres a broad portfolio of Infectious Diseases ELISAs